Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0011849 (
diabetes
)
277,896
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A leukocyte migration inhibition test on the human pancreatic B-cell clone (JHPI-1) was performed in 13 IDDM patients with islet cell cytoplasmic antibody (ICCA) and/or islet cell surface antibody (ICSA), 15 IDDM patients without ICCA or ICSA, 34 NIDDM patients and 17 healthy controls. The mean values for the migration index (M.I. %) in each group were 85.4 +/- 6.9, 89.1 +/- 10.9, 98.3 +/- 7.9 and 100.0 +/- 8.5. The M.I. values were significantly decreased in IDDM patients than in NIDDM patients and controls irrespective of whether or not there were islet cell antibodies in the patients' sera. When M.I. values less than 0.83 (Mean-2 S.D.) were taken as indicative of inhibition, the percentage of IDDM and NIDDM patients with migration inhibition were 32% and 0% respectively. And the decreased M.I. values in IDDM patients proved not to be due to non-specific migration inhibition by normal M.I. values, with the human fetal lung fibroblast cells (W 138) as antigen. Our data suggested that the lymphocytes of IDDM patients might be sensitized by pancreatic B-cell antigen(s) present in the JHPI-1 cells, which promoted leukocyte migration inhibition. No correlation between the migration indices and duration of
diabetes mellitus
in IDDM patients was observed (r = 0.254, Y = 84.9 + 0.49 X).
LMT
to JHPI-1 seems to be useful in detecting the abnormal cell-mediated immunity even in patients with longstanding IDDM.
...
PMID:Cellular hypersensitivity to human pancreatic B-cell clone in diabetes mellitus and its relationship to the presence of islet cell antibodies. 391 Apr 12
Drug-eluting stent which was added to our ammunition in 2002 has greatly changed coronary PCI, especially treatment of
LMT
lesion which had been treated only by CABG. SYNTAX trial recently showed that the outcome of PCI on
LMT
lesion is equivalent to that of CABG if the lesion is not extended and accompanied by any complication. CABG still shows its superiority in case of patients with
diabetes
or highly advanced lesion (SYNTAX Score > or = 33). Stenting in bifurcation lesion of
LMT
is a remaining controversy and development of optimum procedure of such lesion is awaited. As a cardiologist, it is essential to access the option of therapy for each case by consulting with surgeons based on these evidences.
...
PMID:[Current treatment strategy of left main trunk disease--comparison of PCI and CABG]. 2138 71